[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

OAB Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: OA95BA931B7CEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This repor mainly studies OAB (overactive bladder) treatment market. Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).

This report contains market size and forecasts of OAB Treatment in Global, including the following market information:

Global OAB Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global OAB Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anticholinergics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of OAB Treatment include Astellas Pharma, Allergan, Pfizer, Teva (Activas) and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the OAB Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global OAB Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global OAB Treatment Market Segment Percentages, by Type, 2021 (%)
  • Anticholinergics
  • Mirabegron
  • Botox
Global OAB Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global OAB Treatment Market Segment Percentages, by Application, 2021 (%)
  • Idiopathic Overactive Bladder
  • Neurogenic Overactive Bladder
Global OAB Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global OAB Treatment Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies OAB Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies OAB Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Astellas Pharma
  • Allergan
  • Pfizer
  • Teva (Activas)
  • Johnson & Johnson
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 OAB Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global OAB Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OAB TREATMENT OVERALL MARKET SIZE

2.1 Global OAB Treatment Market Size: 2021 VS 2028
2.2 Global OAB Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top OAB Treatment Players in Global Market
3.2 Top Global OAB Treatment Companies Ranked by Revenue
3.3 Global OAB Treatment Revenue by Companies
3.4 Top 3 and Top 5 OAB Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies OAB Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 OAB Treatment Players in Global Market
  3.6.1 List of Global Tier 1 OAB Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 OAB Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global OAB Treatment Market Size Markets, 2021 & 2028
  4.1.2 Anticholinergics
  4.1.3 Mirabegron
  4.1.4 Botox
4.2 By Type - Global OAB Treatment Revenue & Forecasts
  4.2.1 By Type - Global OAB Treatment Revenue, 2017-2022
  4.2.2 By Type - Global OAB Treatment Revenue, 2023-2028
  4.2.3 By Type - Global OAB Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global OAB Treatment Market Size, 2021 & 2028
  5.1.2 Idiopathic Overactive Bladder
  5.1.3 Neurogenic Overactive Bladder
5.2 By Application - Global OAB Treatment Revenue & Forecasts
  5.2.1 By Application - Global OAB Treatment Revenue, 2017-2022
  5.2.2 By Application - Global OAB Treatment Revenue, 2023-2028
  5.2.3 By Application - Global OAB Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global OAB Treatment Market Size, 2021 & 2028
6.2 By Region - Global OAB Treatment Revenue & Forecasts
  6.2.1 By Region - Global OAB Treatment Revenue, 2017-2022
  6.2.2 By Region - Global OAB Treatment Revenue, 2023-2028
  6.2.3 By Region - Global OAB Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America OAB Treatment Revenue, 2017-2028
  6.3.2 US OAB Treatment Market Size, 2017-2028
  6.3.3 Canada OAB Treatment Market Size, 2017-2028
  6.3.4 Mexico OAB Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe OAB Treatment Revenue, 2017-2028
  6.4.2 Germany OAB Treatment Market Size, 2017-2028
  6.4.3 France OAB Treatment Market Size, 2017-2028
  6.4.4 U.K. OAB Treatment Market Size, 2017-2028
  6.4.5 Italy OAB Treatment Market Size, 2017-2028
  6.4.6 Russia OAB Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries OAB Treatment Market Size, 2017-2028
  6.4.8 Benelux OAB Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia OAB Treatment Revenue, 2017-2028
  6.5.2 China OAB Treatment Market Size, 2017-2028
  6.5.3 Japan OAB Treatment Market Size, 2017-2028
  6.5.4 South Korea OAB Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia OAB Treatment Market Size, 2017-2028
  6.5.6 India OAB Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America OAB Treatment Revenue, 2017-2028
  6.6.2 Brazil OAB Treatment Market Size, 2017-2028
  6.6.3 Argentina OAB Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa OAB Treatment Revenue, 2017-2028
  6.7.2 Turkey OAB Treatment Market Size, 2017-2028
  6.7.3 Israel OAB Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia OAB Treatment Market Size, 2017-2028
  6.7.5 UAE OAB Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Astellas Pharma
  7.1.1 Astellas Pharma Corporate Summary
  7.1.2 Astellas Pharma Business Overview
  7.1.3 Astellas Pharma OAB Treatment Major Product Offerings
  7.1.4 Astellas Pharma OAB Treatment Revenue in Global Market (2017-2022)
  7.1.5 Astellas Pharma Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan OAB Treatment Major Product Offerings
  7.2.4 Allergan OAB Treatment Revenue in Global Market (2017-2022)
  7.2.5 Allergan Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer OAB Treatment Major Product Offerings
  7.3.4 Pfizer OAB Treatment Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Teva (Activas)
  7.4.1 Teva (Activas) Corporate Summary
  7.4.2 Teva (Activas) Business Overview
  7.4.3 Teva (Activas) OAB Treatment Major Product Offerings
  7.4.4 Teva (Activas) OAB Treatment Revenue in Global Market (2017-2022)
  7.4.5 Teva (Activas) Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson OAB Treatment Major Product Offerings
  7.5.4 Johnson & Johnson OAB Treatment Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. OAB Treatment Market Opportunities & Trends in Global Market
Table 2. OAB Treatment Market Drivers in Global Market
Table 3. OAB Treatment Market Restraints in Global Market
Table 4. Key Players of OAB Treatment in Global Market
Table 5. Top OAB Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global OAB Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global OAB Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies OAB Treatment Product Type
Table 9. List of Global Tier 1 OAB Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 OAB Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global OAB Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - OAB Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - OAB Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global OAB Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - OAB Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - OAB Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global OAB Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global OAB Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global OAB Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America OAB Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America OAB Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe OAB Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe OAB Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia OAB Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia OAB Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America OAB Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America OAB Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa OAB Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa OAB Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Astellas Pharma Corporate Summary
Table 31. Astellas Pharma OAB Treatment Product Offerings
Table 32. Astellas Pharma OAB Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan OAB Treatment Product Offerings
Table 35. Allergan OAB Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer OAB Treatment Product Offerings
Table 38. Pfizer OAB Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Teva (Activas) Corporate Summary
Table 40. Teva (Activas) OAB Treatment Product Offerings
Table 41. Teva (Activas) OAB Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson OAB Treatment Product Offerings
Table 44. Johnson & Johnson OAB Treatment Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. OAB Treatment Segment by Type in 2021
Figure 2. OAB Treatment Segment by Application in 2021
Figure 3. Global OAB Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global OAB Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global OAB Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by OAB Treatment Revenue in 2021
Figure 8. By Type - Global OAB Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global OAB Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global OAB Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America OAB Treatment Revenue Market Share, 2017-2028
Figure 12. US OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe OAB Treatment Revenue Market Share, 2017-2028
Figure 16. Germany OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia OAB Treatment Revenue Market Share, 2017-2028
Figure 24. China OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America OAB Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa OAB Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE OAB Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Astellas Pharma OAB Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan OAB Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer OAB Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva (Activas) OAB Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson OAB Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications